International Research Journal of Innovations in Engineering and Technology - IRJIET International Open Access, Monthly, Peer Reviewed, Reputed Journal ISSN (online): 2581-3048

Impact Factor (2025): 6.9

DOI Prefix: 10.47001/IRJIET

Forecasting Covid-19 Mortality in Japan

Abstract

In this study, the ANN approach was applied to analyze COVID-19 daily deaths in Japan. The employed data covers the period 1 January 2020 to 20 April 2021 and the out-of-sample period ranges over the period 21 April to 31 August 2021. The residuals and forecast evaluation criteria (Error, MSE and MAE) of the applied model indicate that the model is quite stable. The results of the study indicate that daily COVID-19 deaths in Japan are likely to increase from the start of the forecast period to reach an equilibrium point of approximately 260 deaths per day which will stretch from 20/06/21 to 31/08/21. Therefore there is need for the government of Japan to ensure adherence to safety guidelines while continuing to create awareness about the COVID-19 pandemic and accelerate COVID-19 vaccination.

Country : Zimbabwe

1 Dr. Smartson. P. NYONI2 Mr. Thabani NYONI3 Mr. Tatenda. A. CHIHOHO

  1. ZICHIRe Project, University of Zimbabwe, Harare, Zimbabwe
  2. SAGIT Innovation Center, Harare, Zimbabwe
  3. Independent Health Economist, Harare, Zimbabwe

IRJIET, Volume 5, Issue 6, June 2021 pp. 286-291

doi.org/10.47001/IRJIET/2021.506051

Full Paper
Download

References

  1. Chen  J., Qi  T., & Liu  L (2020). Clinical progression of patients with COVID-19 in Shanghai, China. J Infect 2020; 80:e1–6.
  2. Huang C., Wang Y., Li X (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395:497–506.
  3. Ministry of Health, Labour and Welfare (2020). Current status of the novel coronavirus infection and the response of the MHLW, Available at: https://www.mhlw.go.jp/stf/newpage_09290.html
  4. Ministry of Health, Labour and Welfare (2020). Current status of the novel coronavirus infection and the response of the MHLW, Available at: https://www.mhlw. go.jp/stf/newpage_12312.html
  5. Nobuaki Matsunaga.,  Kayoko Hayakawa., Mari Terada., Hiroshi Ohtsu., Yusuke Asai., Shinya Tsuzuki., Setsuko Suzuki.,  Ako Toyoda.,  Kumiko Suzuki., Mio Endo., Naoki Fujii., Michiyo Suzuki., Sho Saito., Yukari Uemura.,Taro Shibata., Masashi Kondo., Kazuo Izumi., Junko Terada-Hirashima., Ayako Mikami., Wataru Sugiura.,  and Norio Ohmagari (2020). Clinical Epidemiology of Hospitalized Patients with Coronavirus Disease 2019 (COVID-19) in Japan: Report of the COVID-19 Registry Japan, Clinical Infectious Diseases, pp 1-13.
  6. Our World in Data (2020). Japan: coronavirus pandemic. Available at: https:// ourworldindata.org/coronavirus/country/japan?country=~JPN.
  7. Wu Z.,& McGoogan JM (2020). Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323:1239–1242. https://doi.org/10.1001/jama.2020.2648 PMID: 32091533
  8. Yang X., Yu Y., Xu J., Shu H, Xia J., Liu H (2020). Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020; 8:475–481. https://doi.org/10.1016/S2213-2600(20)30079-5 PMID: 32105632

Copyright @ 2026-2017 IRJIET. All Right Reserved.

Developed by Byzero Technologies